This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening | MicrobiomeTrials
← Back to trials NCT07546162
Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-09-14Est. Completion: 2026-12-31
Enrollment target: 280 participantsOther microbiome trials you might be interested in Hypercholesterolaemia
This is a study to evaluate the effect on LDL-C and the safety and tolerability of FDC laroprovstat/rosuvastatin in LLT-…
Dothan, United States Est. completion Jul 30, 2027
Lipid Metabolism Disorders
Background:
Obesity is known to lead to diseases such as diabetes and high cholesterol (or fats) in the blood (hyperlip…
Bethesda, United States Est. completion Nov 30, 2028